HOME >> MEDICINE >> NEWS
Higher dose formulation of FOSRENOL approved to reduce serum phosphorus in esrd patients

PHILADELPHIA, Nov. 28 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a new, higher dose formulation of the chewable(1) non-calcium phosphate binder FOSRENOL(R) (lanthanum carbonate). The new, higher dose strengths of 750 milligrams (mg) and 1.0 gram (g) will be available in the U.S. by year end. This formulation will help to reduce the number of pills end-stage renal disease (ESRD) patients must take to achieve target phosphorus levels, thereby helping to simplify the treatment of hyperphosphatemia. FOSRENOL(R) is marketed by Shire Pharmaceuticals.

Even with a low phosphorus diet, 60 percent of ESRD patients on dialysis in the United States may develop hyperphosphatemia (high phosphorus levels in the blood) and up to 70 percent are considered noncompliant when using currently prescribed phosphate binders. Without effective treatment, hyperphosphatemia may lead to increased rates of death, renal bone disease, hyperparathyroidism and calcification of tissues. Also, evidence shows hyperphosphatemia may contribute to cardiovascular disease, which accounts for almost half of all deaths among dialysis patients. FOSRENOL(R) is indicated to reduce serum phosphorus in patients with ESRD.

"As a result of the FDA approval, FOSRENOL(R) is now available in a new formulation, offering water-sparing, chewable tablets that are smaller than the original formulation. Additionally, FOSRENOL(R) is now available in a broader range of dosage strengths, including the new higher strengths of 750 milligram and 1.0 gram tablets," said Eliseo Salinas, M.D., Shire's Chief Scientific Officer and Executive Vice President of Global Research & Development. "The newly formulated, higher dosage strengths of FOSRENOL(R) allow patients the potential to achieve phosphorus control with as little as three tablets per day."

According to recent data presented at the American Society of Nephrology annual meeting in Philadelphia, PA, the new, highe
'"/>

Contact: Matt Cabrey
mcabrey@us.shire.com
484-595-8800
Porter Novelli
28-Nov-2005


Page: 1 2 3 4 5 6

Related medicine news :

1. Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
2. Higher gas prices leave many workers running on empty
3. Higher calcium and vitamin D intakes positively associated with brain lesions in older men and women
4. Higher physical activity associated with reduced risk of breast cancer
5. Higher levels of cells originating in bone marrow may be useful in prognosis of liver cancer
6. Higher blood pressure associated with decline in walking ability in older persons
7. Higher levels of obesity associated with greater health risks
8. Higher death rates associated with increasing degrees of obesity, PITT researchers report
9. Higher strength MRI can help patients avoid arthroscopy for shoulder injuries
10. Higher self-awareness of memory complaints predict brain function decline
11. Higher rates of infection may explain why women have higher risk of death after bypass surgery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... ... with the use of the Precision Virtual Reality® medical visualization platform by ... neurosurgeons and physicians with a never-before view of the anatomy and pathology ...
(Date:12/5/2018)... ... 05, 2018 , ... Since PermaLip™ implants are solid, patients do ... the naked eye, ensuring a natural look. “I always double and triple check implant ... of implant visibility,” says Dr. Jessica Kulak, double board certified facial plastic surgeon at ...
(Date:12/5/2018)... PORTLAND, Ore. (PRWEB) , ... December 05, 2018 , ... ... True Terpenes and LTRMN. , LTRMN , is a powerhouse in the cannabis ... market share. True Terpenes is an industry leading, award winning , ...
(Date:11/29/2018)... , ... November 29, 2018 , ... ... white paper today, “ Investing in the Future: Why Preventing Chronic Disease is ... interventions in chronic disease prevention, control, and health promotion. , The paper ...
(Date:11/28/2018)... (PRWEB) , ... November 28, 2018 , ... Melania Trump, ... Wednesday as part of a town hall event addressing the national opioid epidemic. The ... host Eric Bolling, who lost his son to an accidental opioid overdose last year. ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... LONDON (PRWEB) , ... December 05, 2018 , ... ... in Cardiff, Wales. The BFE meeting is an interdisciplinary biofeedback conference to ... psychology, medicine, physical therapy, education and other disciplines come together to share and ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs ... today the launch of the Annatto-E™ product line, containing unique and natural vitamin ... clinical research, DFH’s new Annatto-E™ products are available in three dosages of 75mg ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... unique product makes the company’s powerful electronic forms and eSignatures functionality accessible via ... by leaps and bounds in the consumer space and it’s about time hospital ...
Breaking Medicine Technology:
Cached News: